Navigation Links
Ceelox Announces New Patent Issued
Date:5/31/2011

TAMPA, Fla., May 31, 2011 /PRNewswire/ -- Ceelox, Inc. (OTCBB: CELO), (the "Company") proudly announced today that it was issued a patent from the U.S. Patent Office. The patent, U.S. Patent Number 7,945,520 entitled "System and Method for Secure and/or Interactive Dissemination of Information," provides the ability for associating message content with a media element, such as an advertisement, sending the message to a designated recipient, and presenting the media content only after the "unwrapping" of the message through the use of biometric authentication.

The issued patent adds an innovative dimension to online advertising and marketing, allowing advertisers to encrypt unique messages inside electronic images or "wrappers" such as online ads, photographs or artwork, video files, instant messages, and MP3 files. The message is secure; can be delivered via email or through Websites; and gives a user the power to decrypt hidden messages or create their own.

"We are obviously pleased with the U.S. Patent Office's issuance of this patent, which we believe will strengthen our intellectual property protection. This is a significant milestone for our company, and we are very proud of our development team," said Gerry Euston, Ceelox CEO.

About Ceelox, Inc.

Ceelox, Inc. is a developer of biometric security and encryption software solutions for financial institutions, healthcare companies, utilities, government agencies and other organizations for whom information access are key concerns. Its security and encryption tools are easy to deploy, simple to use, cost-effective and affordable for organizations of all sizes.  

Notice Regarding Forward-Looking Statements

This news release contains "forward-looking statements" as that term is defined in Section 27A of the United States Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Statements in this press release which are not purely historical are forward-looking statements and include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities. Actual results could differ from those projected in any forward-looking statements due to numerous factors. Such factors include, among others, the inherent uncertainties associated with new projects and development stage companies. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Although we believe that any beliefs, plans, expectations and intentions contained in this press release are reasonable, there can be no assurance that any such beliefs, plans, expectations or intentions will prove to be accurate. Investors should consult all of the information set forth herein and should also refer to the risk factor disclosure outlined in our Form 8-K filed with the Securities and Exchange Commission on February 12, 2010 and other periodic reports filed from time-to-time with the Securities and Exchange Commission.

For more information visit our website at www.ceelox.com

Investor Relations:
investors@ceelox.com
813-769-0918 x44


'/>"/>
SOURCE Ceelox, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. Ceelox Announces "Compatible with Windows 7" Logo for its Ceelox ID 7 for Personal Computers
2. Ceelox Offers Beta Release of Ceelox ID 7 for Personal Computers
3. Ceelox Provides Biometric Identity Access to Cloud Applications
4. Ceelox Offers Beta Release of Ceelox ID 7 for Personal Computers
5. delSECUR CORPORATION Announces Distribution of Its Asset to Lenders, Subsequent Distribution to Its Shareholders; and Dissolution of the Corporation
6. Virginia Tech announces football helmet ratings for reducing concussion risk
7. Elsevier announces launch of Swarm and Evolutionary Computation
8. Aware, Inc. Announces Resignation of Chief Executive Officer
9. Ennova Direct Announces the Sale of its Consumer Electronics/Computer Peripheral Patent Portfolio
10. MiMedx Group Announces Launch of EpiFix™ and Hiring of Vice President, Wound Care
11. Ahram Biosystems Announces Launch of the Palm PCR(TM) Portable PCR System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2017)... --  Bridge Patient Portal , an enterprise patient ... Systems , an electronic medical record solutions developer ... a partnership to build an interface between the ... products, including Centricity Practice Solution (CPS), Centricity Business ... integrations will allow healthcare delivery networks using GE ...
(Date:4/17/2017)... NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... Annual Report on Form 10-K on Thursday April 13, 2017 with ... ... Relations section of the Company,s website at http://www.nxt-id.com  under "SEC ... . 2016 Year Highlights: Acquisition ...
(Date:4/11/2017)... , April 11, 2017 No two ... researchers at the New York University Tandon School ... Engineering have found that partial similarities between prints ... used in mobile phones and other electronic devices ... The vulnerability lies in the fact that ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... , ... October 12, 2017 ... ... announces publication of a United States multicenter, prospective clinical study that demonstrates ... point-of-care diagnostic test capable of identifying clinically significant acute bacterial and viral ...
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 system ... experiments and avoiding the use of exogenous expression plasmids. The simplicity of programming ... systematic gain-of-function studies. , This complement to loss-of-function studies, such as with ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. 11, ... Research, London (ICR) and University of ... SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma (MM), ... nine . The University of Leeds ... funded by Myeloma UK, and ICR will perform the testing ...
(Date:10/10/2017)... Angeles, CA (PRWEB) , ... ... ... Inc., a development-stage cancer-focused pharmaceutical company advancing targeted antibody-drug conjugate (ADC) therapeutics, ... uses of targeted HPLN (Hybrid Polymerized Liposomal Nanoparticle), a technology developed in ...
Breaking Biology Technology: